Клиничеcкое значение иммунофенотипирования cерозной аденокарциномы яичников
Диссертация
Работа Sato Е. et al. (2005) проведена на архивном материале 117 удаленных в ходе хирургического вмешательства злокачественных эпителиальных опухолей яичников. Доказана роль С08±лимфоцитов, инфильтрирующих зоны опухолевого роста, в прогнозе РЯ. У больных с более высокими значениями CD8±TITJI в сравнении с группой с низкими показателями этих клеток отмечены большая продолжительность жизни (медианы… Читать ещё >
Список литературы
- Давыдов, М.И. Статистика злокачественных новобразований в России и странах СНГ в 2005 г. /М.И. Давыдов, Е. М. Аксель //Вестник РОНЦ им. Н. Н. Блохина. — 2007. — 18(2):прил.1.
- Артамонова, Е.В. Местные иммунные реакции при раке молочной железы. В кн.: Рак молочной железы: иммунологические факторы прогноза. /Е.В. Артамонова, Н. А. Огнерубов, Н. Н. Тупицын, В. П. Летягин. — Воронеж, 2005. —С. 89−137.
- Барышников, А.Ю. Взаимоотношение опухоли и иммунной системы организма. /А.Ю. Барышников //Практическая онкология. — 2003. — 4(3). — С. 127−130.
- Никулин, М.П. Экспрессия рецептора трансферрина на клетках рака желудка. /М.П. Никулин, Н. Н. Тупицын, В. Ю. Сельчук, В. И. Роттенберг // Российский онкологический журнал. — 2002. — 4. — С. 17−20.
- Никулин, М.П. Иммунофенотипическая гетерогенность рака желудка: 15-летний опыт исследований. / М. П. Никулин, С. В. Овсянников, Н. Н. Тупицын // Иммунология гемопоэза. — 2004. — 1. — С. 133−144.
- Tupitsyn, N.N. Relationship between semiquantitative and quantitative parameters of local immune response in gastric cancer. / N.N. Tupitsyn, Z.G.Kadagidze, I.K. Tuichev //Experimental Oncology. — 1995. — 17(1). — P. 31−36.
- Albelda, S.M. Role of integrins and other cell adhesion molecules in tumor progression and metastasis. / S.M. Albelda //Lab. Invest. —1993. — 68. — P. 4−17.
- Alvaro, T. Outcome in Hodgkin’s lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T-cells. /T. Alvaro, M. Lejeune, M.T. Salvado et al. // Clin Cancer Res. — 2005. — 11. — P. 146 773.
- Andersen, S.N. Strong HLA-DR expression in large bowel carcinomas is associated with good prognosis. /S.N. Andersen, T.O. Rognum, E. Lund, G.I.Meling, S. Hauge //Br J Cancer. — 1993. — Jul-68(l).— P. 80−5.
- Brackenbury, R. Expression of neural cell adhesion molecules in normal and pathologic tissues. / R. Brackenbury//Ann NY Acad Sci. — 1988. — 540. — P. 39−46.
- Calzolari, A. Regulation of transferring receptor 2 in human cancer cell lines. /A. Calzolari, V. Finisguerra, I. Oliviero, S. Deaglio, G. Mariani //Blood Cells, Molecules, and Diseases. — 2009. — 42. — P. 5−13.
- Campbell, R.D. Map of human MHC. /R.D. Campbell, J. Trowsdale // Immunol Today. — 1993. — 14. — P. 349−52.
- Casey, R.C. CD44 and betal integrins mediate ovarian carcinoma cell migration toward extracellular matrix proteins. /R.C.Casey, A.P. Skubitz // Clin Exp Metastasis. — 2000. —18(1). — P. 67−75.
- Clezardin, P. Recent insights into the role of integrins in cancer metastasis. /P. Clezardin // Cell. Mol. Life Sci. — 1998. — 54. — P. 541−548.
- Concha, A. Tumor aggressiveness and MHC class I and II antigens in laryngeal and breast cancer. /A. Concha, F. Esteban, T. Cabrera, F. Ruiz-Cabello, F. Garrido // Semin Cancer Biol. — 1991. — Feb-2(l). — P. 47−54.
- Curiel, T.J. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival./ Curiel, T.J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M.,
- Conejo-Garcia, J. R., Zhang, L., Burow, M., et al. Nat. Med. — 2004. — 10. — P. 942
- Chen, M.L. Regulatory T-cells suppress tumor-specific CD8 T-cell cytotoxicity through TGF-B signals in vivo. /M.L. Chen, M.J. Pittet, L. Gorelik et al. // Proc Natl Acad Sci USA. — 2005. — 102. P. 419−24.
- Cho, E.Y. Immunohistochemical study of the expression of adhesion molecules in ovarian serous neoplasm. /E.Y. Cho, Y. Choi, S.W. Chae, J.H. Sohn, G.H. Ahn//Pathol Int. — 2006. — Feb. 56(2). — P. 62−70.
- Dong, Y. Expression of MUC1 and MUC2 mucins in epithelial ovarian tumours. /Y. Dong, M.D. Walsh, M.C. Cummings, R.G. Wright, S.K. Khoo, P.G.Parsons, M.A. McGuckin // The Journal of pathology. — 1997. — 183(3). — P. 311−7.
- Edelman, G.M. Cell adhesion molecules: implications for a molecular histology. / Edelman, G.M., Crossin, K.L. //Annu Rev Biochem. — 1991. — 60. — P.155−190.
- El Demellawy, D. Diagnostic utility of CD56 immunohistochemistry in papillary carcinoma of the thyroid. /D. El Demellawy, A.L. Nasr, S. Babay, S. Alowami // Pathol Res Pract. — 2009. — 205(5). — P. 303−9. Epub 2009 Jan 18.
- El Demellawy, D. Application of CD56, P63 and CK19 immunohistochemistry in the diagnosis of papillary carcinoma of the thyroid. /D.E1 Demellawy, A. Nasr, S. Alowami // Diagn Pathol. — 2008. — Feb. 6−3:5.
- Feng, H. Expression of MUC1 and MUC2 Mucin Gene Products in Human Ovarian Carcinomas. /H. Feng, M. Ghazizadeh, H. Konishi, T. Araki // Jpn. J. Clin. Oncol. — 2002. — December 1. — 32(12). — P. 525−529.
- Fujiwara, H. Human leukocyte antigen -DR is a different antigen for human granulosa cells. /H. Fujiwara, M. Ueda, K. Imai, M. Fucuoka, K. Yasuda, K. Nakakura, H. Sugumani //Biol Reprod. — 1993. — 49. — P. 705−15.
- Filiz, S. Localization of neural cell adhesion molecule (NCAM) immunoreactivity in adult rat tissues. / S. Filiz, H. Dalcik, M. Yardimoglu, S. Gonca, S. Ceylan // Biotech Histochem. — 2002. — May-77(3). — P. 127−35.
- Fontenot, J.D. Foxp3 programs the development and function of CD4+CD25+ regulatory T-cells. /J.D/ Fontenot, M.A. Gavin, A.Y. Rudensky // Nat. Immunol. — 2003. — 4. — P. 330−6.
- Gargett, C.E. Isolation and Culture of Epithelial Progenitors and Mesenchymal Stem Cells from Human Endometrium. /C.E. Gargett, K.E. Schwab, R.M. Zillwood, H.P. Nguyen, D. Wu // Biol Reprod. — 2009. — Feb 18. Epub ahead of print.
- Garrido, F. Natural history of HLA expression during tumor development. / F. Garrido, T. Cabrera, A. Concha, S. Glew, P.L. Stern // Immunol Today. — 1993. — 14, —P. 491−99.
- Garrido, F. HLA class I antigens in human tumors. /F. Garrido, T. Cabrera, M.A. Lopez-Nevot, F. Ruiz-Cabello // Adv. Cancer Res. — 1995. — 67. —P. 155−95.
- Hammerling, G.L. The influence of major histocompatibiliti complex class I antigens on tumor growth and metastasis. /G.L. Hammerling, D. Klar, W. Pulm // Bioch. and Bioph. Acta. — 1987. — Vol. 907. — N3. — P. 245−258.
- Hickin, D. HLA class I antigen downregulation in human cancers: T-cells immunotherapy revives an old story. /D. Hickin, F.M. Marincola, S. Ferrone // Mol Med Today. — 1999. — 5. — P. 178−86.
- Howard, M.C. MHC-based diagnostics and therapeutics. / Howard M.C., Spack E.G., Choudhury K., Greten T.F. // Immunol Today. — 1999. — 20.1. P. 161−65.
- Jager E. Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: Definition of human histocompatibility leukocyte antigen (HLA) — A2-binding peptide epitopes. Jager E., Chen Y.T., Drijfhout J.W.,
- Karbach J., Ringhoffer M., Jager D., Arand M., Wada H., Noguchi Y., Stockert E., et al. J Exp Med. — 1998. — 187. —P. 265−270.
- Janssens, W. CD4+CD25+ T cells lyse antigen-presenting B-cells by Fas-Fas ligand interaction in an epitope-specific manner. / Janssens W., Carlier V., Wu B., Vander Eist L., Jacquemin M.G., Saint-Remy J.M. //J Immunol. — 2003. — 171. — P. 4604−12.
- Jurisic, V. The role of cytokine in regulation of the natural killer cell activity. /V. Jurisic, S. Stojacic-Djenic, N. Colovic, G. Konjevic // Srp Arh Celok Lek. — 2008. — Jul-Aug- 136(7−8). — P. 423−9.
- Hicklin, D.J. HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story. /D.J. Hicklin, F.M. Marincola, S. Ferrone // Mol Med Today. — 1999. — Apr- 5(4). — P. 178−86.
- Hori, S. Control of regulatory T-cell development by the transcription factor Foxp3. / S. Hori, T. Nomura, S. Sakaguchi // Science. — 2003. — 299. — P. 1057−61.
- Kabawat, S.E. Expression of major histocompatibility antigens and nature of inflammatory cellular infiltrate in ovarian neoplasms. /S.E. Kabawat, R.C.Jr. Bast, W.R. Welch, R.C. Knapp, A.K. Bhan// Int J Cancer. — 1983. — Nov 15. —32(5). —P. 547−54.
- Kondo, K. Transferring receptor expression in adenocarcinoma of the lung as a histopathologic indicator of prognosis. /K. Kondo, M. Noguchi, K. Mukai //Chest. — 1990,—Vol. 97.—N6, — P. 1367^-1371.
- Kubler, K. HLA-class II haplotip association with ovarian cancer / K. Kubler, P.F. Arndt, E. Wardermann, D. Krebs, W. Kuhn, K. van der Ven // International jornal of Cancer. — 15.12. 2006. — P. 2980−2985.
- Kuhn, A. CD4(+)CD25 (+) regulatory T-cells in human lupus erythematosus. /A. Kuhn, S. Beissert, P.H. Krammer // Arch Dermatol Res. — 2009. — Jan-301(l). — P. 71−81. Epub 2008. Nov 5.
- Kumar, C.C. Signaling by integrin receptors. /C.C. Kumar // Oncogene. — 1998. — 17. —P. 1365−1373.
- Limas, C. Proliferative activity of normal and neoplastic urothelium and its relation to epidermal growth factor and transferrin receptors. /C. Limas, R. Bair, P. Bernhart, P. Reddy //J Clin Pathol. — 1993. — Sep-46(9). — P. 810−6.
- Martoglio, A.M. Changes in tumorigenesis- and angiogenesis-related gene transcript abundance profiles in ovarian cancer detected by tailored high density cDNA arrays. /A.M. Martoglio, B.D. Tom, M. Starkey, A.N. Corps,
- D.S. Charnock-Jones, S.K. Smith //Mol Med. — 2000. — Sep-6(9). — P. 750−65.
- Matsushita, N. Association of ovarian tumor epithelium coexpressing HLA-DR and CA-125 antigens with tumor infiltrating cytotoxic T-lymphocytes. /N. Matsushita, M. Ghazizadeh, H. Konishi, T. Araki // J Nippon Med Sch. — 2003. — Feb. — 70(1). — P. 40−4.
- Merlo, A. FOXP3 expression and overall survival in breast cancer. /A.Merlo, P. Casalini, M.L. Carcangiu, C. Malventano, T. Triulzi, S. Menard,
- E.Tagliabue, A. Balsari // J Clin Oncol. — 2009. — Apr 10. — 27(11). — P. 1735−6.
- Mjaller, C.J. N-CAM in developing mouse gonads and ducts. /C.J.Moller, A.G. Byskov, J. Roth, J.E. Celis, E. Bock // Anat Embryol (Berl). — 1991. — 184(6). —P. 541−8.
- Moser, T.L. Evidence for preferential adhesion of ovarian epithelial carcinoma cells to type I collagen mediated by the a2l31 integrin. /T.L. Moser, S.V.Pizzo, L.M. Bafetti, D.A. Fishman, M.S. Stack //Int. J. Cancer. — 1996. — 67. —P. 695−701.
- Moore, D.H. Class I histocompatibility antigen expression: a prognostic factor for aneuploid ovarian cancers./ D.H. Moore, W.C. Jr. Fowler, K. Olafsson //Gynecol. Oncol. — 1990. — Sep., 38(3). — P. 458−61.
- Naito, Y. CD8+ T Cells Infiltrated within Cancer Cell Nests as a Prognostic Factor in Human Colorectal Cancer. /Y. Naito, K. Saito, K. Shiiba, A. Ohuchi, K. Saigenji, H. Nagura, H. Ohtani //Cancer Research. — 1998. — August 15. — 58. — P. 3491−3494.
- Nishikawa, H. CD4+CD25+ regulatory T-cells control the induction of antigen-specific CD4+ helper T-cell responses in cancer patients. /H. Nishikawa, E. Jager, G. Ritter, L.J. Old, S. Gnjatic //Blood. — 2005. — 106. — P. 1008−11.
- Ohishi, Y. CD56 expression in ovarian granulosa cell tumors, and its diagnostic utility and pitfalls. /Y. Ohishi, T. Kaku, M. Oya, H. Kobayashi, N. Wake, M. Tsuneyoshi //Gynecol Oncol. — 2007. — Oct- 107(1). — P. 30−8. Epub 2007. Jun 20.
- D. Tamiolakis //Eur J Gynaecol Oncol. — 2002. — 23(6). — P. 533−6.
- Pearson, J.W. Restoration of interferon alpha potentiation of a recombinant ricin A chain immunotoxin following cytoreduction of xenografts of advanced ovarian tumors. / J.W. Pearson, W.E. Fogler, K. Volker, C.W. Riggs,
- E.Gruys, E.S. Groves, R.H. Wiltrout, D.L. Longo //J Natl Cancer Inst. — 1993. — Jun 2. — 85(11). — P. 907−12.
- Prall, F. Prognostic role of CD8+ tumor-infiltrating lymphocytes in stage III colorectal cancer with and without microsatellite instability. /F. Prall, T. Diihrkop, V. Weirich et al. //Hum Pathol. — 2004. — 35. — P. 808−16.
- Prasad, S.J.D endritic cells loaded with stressed tumor cells elicit long-lasting protective tumor immunity in mice depleted of CD4+CD25+ regulatory T-cells. /S.J. Prasad, K.J. Farrand, S.A. Matthews, J.H. Chang, R.S. McHugh,
- F.Ronchese // J Immunol. — 2005. — 174. — P. 90−8.
- Ruiter, D.J. MHC antigens in human melanomas. /D.J. Ruiter, V. Mattijssen, E.B. Broecker, S. Ferrone. // Semin Cancer Biol. — 1991. — Feb. 2(1). —P. 35−45.
- Ruiz-Cabello, F. MHC antigens on human tumor. /F. Ruiz-Cabello, E. Klein, F. Garrido // Immunol let. — 1991. — 29. — P. 181−90.
- Ruoslahti, E. Integrins. /E. Ruoslahti //J. Clin. Invest. — 1991. — 87.1. P. 1−5.
- Ryu, K.S. Alterations of class I and class II antigen expression in preinvasive, invasive and metastatic cervical cancers. /K.S. Ryu, Y.S. Lee, B.K.Kim, Y.G. Parc, Y.W. Kim, S.Y. Hur, T.E. Kim //Exp. Mol. Med. —2001. — 33. —P. 136−44.
- Sakaguchi, S. Naturally arising CD4+ regulatory T-cells for immunologic self-tolerance and negative control of immune responses. /S.Sakaguchi //Annu Rev Immunol. — 2004. — 22. — P. 531−6.
- Sanders, R.J. The role of integrins in tumorogenesis and metastasis. /R.J.Sanders, F. Mainiero, F.P. Giancotti //Cancer Invest. —1998. — 16. — P. 329−344.
- Sasada, T. CD4+CD25+ regulatory T-cells in patients with gastrointestinal malignancies: possible involvement of regulatory T-cells in diseaseprogression. /T. Sasada, M. Kimura, Y. Yoshida, M. Kanai, A. Takabayashi //Cancer. — 2003. — 98. — P. 1089−99.
- Sato, E. Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T-cells ratio are associated with favorable prognosis in ovarian cancer. IE. Sato, S.H. Olson, J. Ahn //PNAS. — 2005. — 102(51). — P. 1 853 818 543.
- Seo, S.J. The impact of T-helper and T-regulatory cells on the regulation of anti-double-stranded DNA B-cells. /S.J. Seo, M.L. Fields, J.L. Buckler et al. // Immunity. — 2002. — 16. — P. 535−46.
- Schumacher, K. Prognostic significance of activated CD8(+) T-cell infiltrations within esophageal carcinomas. /K. Schumacher, W. Haensch, C. Roefzaad, P.M. Schlag //Cancer Res. — 2001. — 61. — P. 3932−3936.
- Skubitz, A.P. Adhesion molecules. /A.P. Skubitz// Cancer Tret Res. — 2002. — 107. — P. 305−29.
- Tamiolakis, D. Prognostic significance of HLA-DR antigen in serous ovarian tumors. /D. Tamiolakis, A. Kotini, J. Venizelos, T. Jivannakis,
- C.Simopoulos, N. Papadopoulos N. //Clin Exp Med. — 2003. — Sep-3(2). — P. 113−8.
- Tashiro, Y. Immunohistochemical study of mucin carbohydrates and core proteins in human ovarian tumors. /Y. Tashiro, S. Yonezawa, Y.S. Kim, E. Sato //Hum Pathol. — 1994. — Apr-25(4). — P. 364−72.
- Helal, T. of Tumor-Infiltrating Mononuclear Cells in Ovarian Carcinoma /T. Helal, A. Alia, M. Laban, R. Fahmy // Pathology Oncologi Research. — 2007. — N 2. — Vol 10.
- Thiery, J.P. Adhesion mechanisms in embryogenesis and in cancer invasion and metastasis. /J.P. Thiery, B. Boyer, G. Tucker, J. Gavrilovic, A.M.Valles// Ciba Found Symp. — 1988. — 141. — P. 48−74.
- Tomsova, M. Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma. /M. Tomsova, B. Melichar, I. Sedlakova, I. Steiner //Gynecol Oncol. — 2008. — Feb- 108(2). — P. 415−20.
- Whiteman, K.R. Preclinical Evaluation of IMGN901 (huN901-DMl) as a Potential Therapeutic for Ovarian /K.R. Whiteman, M.F. Murphy, K.P. Cohane, W. Sun // Cancer. — 2008.
- Wolf, A.M. Increase of regulatory T-cells in the peripheral blood of cancer patients. /A.M. Wolf, D. Wolf, M. Steurer, G. Gastl, E. Gunsilius, B. Grubeck-Loebenstein // Clin Cancer Res. — 2003. — 9. — P. 606−12.
- Woo, E.Y. Regulatory CD4(+)CD25(+) T-cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer. / E.Y.Woo, C.S. Chu, T.J. Goletz et al. //Cancer Res. — 2001. — 61. — P. 476 672.
- Woo, E.Y. Cutting edge: regulatory T-cells from lung cancer patients directly inhibit autologous T-cell proliferation. /E.Y. Woo, H. Yeh, C.S. Chu et al. // J Immunol. — 2002. — 168. — P. 4272−6.
- Yamamoto, M. A novel monoclonal antibody specific for sialylated MUC1 mucin. /M. Yamamoto, V.P. Bhavanabdan, S. Nakamory, T. Irimura //Jpn J Cancer Res. — 1996. — 87. — P. 488−96.
- Yagi, H. Crucial role of FOXP3 in the development and function of human CD25 +CD4+ regulatory T-cells. /H. Yagi, T. Nomura, K. Nakamura et al. //Int Immunol. — 2004. — 16. — P. 1643−56.
- Zang, L. Intratumoral T-cells, Recurrence, and Survival in Epithelial Ovarian Cancer. /L. Zang, J.R.Conero-Garcia, D. Katsaros // N ENG J Med. — 2003. — 348(3). —P. 203−213.